bioMérieux S.A. (BMXXY)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16,898	12,645	13,135	12,388	16,809	16,702
Market Cap Growth	-3.73%	-3.73%	6.03%	-26.30%	0.64%	58.81%
Enterprise Value	16,952	12,954	13,226	12,508	16,903	16,991
Last Close Price	13.83	9.42	9.42	10.70	-	-
PE Ratio	37.76	28.26	33.23	25.62	24.59	33.76
PS Ratio	4.10	3.07	3.23	3.23	4.38	4.38
PB Ratio	3.88	2.90	3.17	3.18	4.67	5.50
P/TBV Ratio	5.47	4.10	4.71	5.35	7.28	9.96
P/FCF Ratio	50.77	37.99	110.96	61.52	27.65	44.72
P/OCF Ratio	24.46	18.30	26.68	24.40	17.92	23.43
EV/Sales Ratio	3.69	3.14	3.26	3.26	4.40	4.45
EV/EBITDA Ratio	14.95	13.20	13.95	13.73	14.79	17.44
EV/EBIT Ratio	23.02	19.61	21.03	19.09	18.27	22.68
EV/FCF Ratio	50.93	38.92	111.72	62.12	27.80	45.50
Debt / Equity Ratio	0.12	0.12	0.14	0.14	0.15	0.19
Debt / EBITDA Ratio	0.50	0.50	0.58	0.57	0.45	0.59
Debt / FCF Ratio	1.53	1.53	4.84	2.68	0.87	1.58
Asset Turnover	0.72	0.72	0.70	0.73	0.79	0.81
Inventory Turnover	1.81	1.81	1.97	2.33	2.37	2.63
Quick Ratio	1.22	1.22	1.12	1.25	1.58	1.16
Current Ratio	2.20	2.20	2.03	1.96	2.29	1.80
Return on Equity (ROE)	10.68%	10.68%	8.73%	12.95%	21.19%	17.01%
Return on Assets (ROA)	7.23%	7.23%	6.81%	7.83%	11.92%	9.93%
Return on Capital (ROIC)	8.89%	8.89%	8.45%	9.86%	15.43%	13.18%
Return on Capital Employed (ROCE)	13.80%	13.80%	13.60%	15.10%	22.30%	20.40%
Earnings Yield	2.65%	3.54%	3.01%	3.90%	4.07%	2.96%
FCF Yield	1.97%	2.63%	0.90%	1.63%	3.62%	2.24%
Dividend Yield	0.42%	9.89%	9.98%	8.49%	-	-
Payout Ratio	-	-	-	22.37%	12.16%	5.56%
Buyback Yield / Dilution	0.06%	0.06%	-0.32%	0.39%	-0.20%	0.05%
Total Shareholder Return	0.47%	9.95%	9.66%	8.88%	-0.20%	0.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.